Childress Capital Advisors, LLC Abbott Laboratories Transaction History
Childress Capital Advisors, LLC
- $366 Million
- Q3 2024
A detailed history of Childress Capital Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Childress Capital Advisors, LLC holds 5,231 shares of ABT stock, worth $593,195. This represents 0.16% of its overall portfolio holdings.
Number of Shares
5,231
Previous 4,606
13.57%
Holding current value
$593,195
Previous $478,000
24.69%
% of portfolio
0.16%
Previous 0.14%
Shares
14 transactions
Others Institutions Holding ABT
# of Institutions
3,162Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.19M-
Vanguard Group Inc Valley Forge, PA166MShares$18.9 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.9 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.44 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.14 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.49 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $199B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...